European Journal of Endocrinology

Papers
(The H4-Index of European Journal of Endocrinology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study625
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management344
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study198
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study136
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men109
18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study87
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment83
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock76
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis76
When selection becomes selection bias69
Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps63
Serum diiodotyrosine – a biomarker to differentiate destructive thyroiditis from Graves’ disease60
Primary adrenal insufficiency in patients with CPOX gene mutations60
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co59
Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study57
High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies52
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?45
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial45
Genome-wide analysis of thyroid function in Australian adolescents highlights SERPINA7 and NCOA344
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy44
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls42
Cardiovascular risk in Danish transgender persons: a matched historical cohort study40
Transcriptional comparison of testicular adrenal rest tumors with fetal and adult tissues40
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis40
Bone strain index for fracture risk assessment in older men—the prospective STRAMBO study39
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?39
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis37
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial37
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis36
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors35
25-OHD response to vitamin D supplementation in children: effect of dose but not GC haplotype34
Comment on the 2021 EUGOGO Clinical Practice Guidelines for the Medical Management of Graves’ Orbitopathy33
Parathyroid hormone in situ measurement in patients with hyperparathyroidism: single-centre experience of 179 patients32
Soluble alpha klotho—impact of biological variables and reference intervals for adults32
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors32
Primary hyperaldosteronism induces congruent alterations of sodium homeostasis in different skeletal muscles: a 23Na-MRI study32
0.070570945739746